ReviewCurrent oncology (Toronto, Ont.)2025

New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2-Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III.

Nicola Battelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.